Literature DB >> 20118067

A patient with SLE-associated thrombotic microangiopathy and non-neutralizing antibodies against ADAMTS13.

Margrith E Knecht1, Michael Mayr, Silvia Ferrari, Friedrich Scheiflinger, Marten Trendelenburg.   

Abstract

In this case report, we describe for the first time a patient with thrombotic thrombocytopaenic purpura (TTP) accompanying highly active systemic lupus erythematosus (SLE) that was associated with non-neutralizing antibodies against the plasma metalloprotease ADAMTS13. Those non-neutralizing antibodies could have been the cause of ADAMTS13 depletion and consecutive TTP. More extensive analyses are required to determine the prevalence as well as the clinical relevance of non-neutralizing antibodies against ADAMTS13 in SLE patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20118067     DOI: 10.1093/ndt/gfq021

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

1.  Concomitant thrombotic thrombocytopenic purpura and ANCA-associated vasculitis in an adolescent.

Authors:  Varun Agrawal; Chirag K Vaidya; Jiuming Ye; Jonathan Freeman; Christine McKiernan; Peter R Blier; Chester Andrzejewski; Michael Germain; Gregory L Braden
Journal:  Pediatr Nephrol       Date:  2011-04-16       Impact factor: 3.714

2.  Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.

Authors:  Shinya Nakayama; Shuma Hirashio; Haruka Yorishima; Toshiki Doi; Yoko Yoshida; Masanori Matsumoto; Takao Masaki
Journal:  CEN Case Rep       Date:  2019-06-08

3.  Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus.

Authors:  Jessica S Kleer; Pascal A Rabatscher; Jessica Weiss; Joel Leonardi; Severin B Vogt; Andrea Kieninger-Gräfitsch; Carlo Chizzolini; Uyen Huynh-Do; Camillo Ribi; Marten Trendelenburg
Journal:  Front Immunol       Date:  2022-01-11       Impact factor: 7.561

4.  Anti-C1q autoantibodies from systemic lupus erythematosus patients enhance CD40-CD154-mediated inflammation in peripheral blood mononuclear cells in vitro.

Authors:  Pascal Alexander Rabatscher; Marten Trendelenburg
Journal:  Clin Transl Immunology       Date:  2022-08-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.